CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-29 | Wolff Allen CEO | Shares withheld for taxes | −170 | $3.15 | $536 | 147,451 |
| 2020-06-29 | Gurrola Sandra M SVP of Finance | Shares withheld for taxes | −97 | $3.15 | $306 | 32,091 |
| 2020-06-17 | ELLIN ROBERT S 10% owner | Sale | −12,400 | $6.01 | $75K | 187,094 |
| 2020-06-16 | ELLIN ROBERT S 10% owner | Sale | −100 | $3.86 | $386 | 199,494 |
| 2020-06-03 | Berg Jeffrey Alan 10% owner | Sale | −21,932 | $1.10 | $24K | 276,100 |
| 2020-06-02 | Berg Jeffrey Alan 10% owner | Sale | −30,730 | $0.99 | $30K | 297,440 |
| 2020-06-01 | Berg Jeffrey Alan 10% owner | Sale | −30,000 | $1.06 | $32K | 328,170 |
| 2020-05-29 | Berg Jeffrey Alan 10% owner | Sale | −25,000 | $1.06 | $26K | 358,170 |
| 2020-05-28 | Berg Jeffrey Alan 10% owner | Sale | −12,338 | $1.08 | $13K | 383,170 |
| 2020-05-27 | Berg Jeffrey Alan 10% owner | Sale | −5,000 | $1.11 | $6K | 395,508 |
| 2020-05-26 | Berg Jeffrey Alan 10% owner | Sale | −20,000 | $1.09 | $22K | 400,508 |
| 2020-05-20 | Gurrola Sandra M SVP of Finance | Shares withheld for taxes | −115 | $1.55 | $178 | 32,188 |
| 2020-05-20 | Wolff Allen CEO | Shares withheld for taxes | −164 | $1.55 | $254 | 147,621 |
| 2020-04-21 | Gurrola Sandra M SVP of Finance | Shares withheld for taxes | −1,392 | $1.21 | $2K | 32,303 |
| 2020-04-21 | Wolff Allen CEO | Shares withheld for taxes | −2,363 | $1.21 | $3K | 147,785 |
| 2020-03-27 | Wolff Allen CEO | Grant or award | +1,271 | $1.48 | $2K | 140,642 |
| 2020-03-27 | Wolff Allen CEO | Grant or award | +9,506 | $1.48 | $14K | 150,148 |
| 2020-03-27 | Wolff Allen CEO | Grant or award | +1,074 | $1.48 | $2K | 140,642 |
| 2020-03-27 | Wolff Allen CEO | Grant or award | +10,580 | $1.48 | $16K | 151,222 |
| 2020-03-25 | Wolff Allen CEO | Shares withheld for taxes | −207 | $1.48 | $306 | 139,371 |
Page 9 of 33 · 657 trades